Vpr Promotes Macrophage-Dependent HIV-1 Infection of CD4+ T Lymphocytes
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Vpr is a conserved primate lentiviral protein that promotes infection of T lymphocytes in vivo by an unknown mechanism. Here we demonstrate that Vpr and its cellular co-factor, DCAF1, are necessary for efficient cell-to-cell spread of HIV-1 from macrophages to CD4+ T lymphocytes when there is inadequate cell-free virus to support direct T lymphocyte infection. Remarkably, Vpr functioned to counteract a macrophage-specific intrinsic antiviral pathway that targeted Env-containing virions to LAMP1+ lysosomal compartments. This restriction of Env also impaired virological synapses formed through interactions between HIV-1 Env on infected macrophages and CD4 on T lymphocytes. Treatment of infected macrophages with exogenous interferon-alpha induced virion degradation and blocked synapse formation, overcoming the effects of Vpr. These results provide a mechanism that helps explain the in vivo requirement for Vpr and suggests that a macrophage-dependent stage of HIV-1 infection drives the evolutionary conservation of Vpr.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MR recognition of HIV Env disrupts infection by promoting lysosomal degradation of Env and Env-containing viral particles33,35.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [33]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“We previously reported that Vpr counteracts accelerated degradation of the HIV Env protein, which occurs in HIV-infected macrophages but not T cells33,34.”
From HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages (2024) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Rabson, A., & Martin, M. A. (1986) · Journal of Virology · doi:10.1128/jvi.59.2.284-291.1986 · Cited by 2,834
Connor, R. I., Chen, B. K., Choe, S., & Landau, N. R. (1995) · Virology · doi:10.1006/viro.1995.1016 · Cited by 1,253
Zwick, M. B., Labrijn, A. F., Wang, M., Spenlehauer, C., Saphire, E. O., Binley, J. M., Moore, J. P., Stiegler, G., Katinger, H., Burton, D. R., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10892-10905.2001 · Cited by 797
Human Immunodeficiency Virus Type 1 Spinoculation Enhances Infection through Virus Binding
O'Doherty, U., Swiggard, W. J., & Malim, M. H. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.10074-10080.2000 · Cited by 664
Burton, D. R., Barbas, C. F., Persson, M. A., Koenig, S., Chanock, R. M., & Lerner, R. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10134 · Cited by 663
TRIM5 is an innate immune sensor for the retrovirus capsid lattice
Pertel, T., Hausmann, S., Morger, D., Züger, S., Guerra, J., Lascano, J., Reinhard, C., Santoni, F. A., Uchil, P. D., Chatel, L., et al. (2011) · Nature · doi:10.1038/nature09976 · Cited by 645
HIV-1 Cell to Cell Transfer across an Env-induced, Actin-dependent Synapse
Jolly, C., Kashefi, K., Hollinshead, M., & Sattentau, Q. J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20030648 · Cited by 623
BUCHACHER, A., PREDL, R., STRUTZENBERGER, K., STEINFELLNER, W., TRKOLA, A., PURTSCHER, M., GRUBER, G., TAUER, C., STEINDL, F., JUNGBAUER, A., et al. (1994) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1994.10.359 · Cited by 529
Goh, W. C., Rogel, M. E., Kinsey, C. M., Michael, S. F., Fultz, P. N., Nowak, M. A., Hahn, B. H., & Emerman, M. (1998) · Nature Medicine · doi:10.1038/nm0198-065 · Cited by 518
Rogel, M. E., Wu, L. I., & Emerman, M. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.882-888.1995 · Cited by 406
Cited by
Clayton, K., Collins, D. R., Lengieza, J., Ghebremichael, M. S., Dotiwala, F., Lieberman, J., & Walker, B. D. (2018) · Nature Immunology · doi:10.1038/s41590-018-0085-3 · Cited by 159
Self-citationHIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages
Lahouassa, H., Blondot, M.-L., Chauveau, L., Chougui, G., Morel, M., Leduc, M., Guillonneau, F., Ramirez, B. C., Schwartz, O., & Margottin-Goguet, F. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600485113 · Cited by 100
Lv, L., Wang, Q., Xu, Y., Tsao, L.-C., Nakagawa, T., Guo, H., Su, L., & Xiong, Y. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.05.007 · Cited by 100
The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention
González, M. E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010126 · Cited by 94
HIV reprograms host m6Am RNA methylome by viral Vpr protein-mediated degradation of PCIF1
Zhang, Q., Kang, Y., Wang, S., Gonzalez, G. M., Li, W., Hui, H., Wang, Y., & Rana, T. M. (2021) · Nature Communications · doi:10.1038/s41467-021-25683-4 · Cited by 70
Clayton, K., Mylvaganam, G., Ocando, A. V., Stuart, H., Maus, M. V., Rashidian, M., Ploegh, H. L., & Walker, B. D. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.01.006 · Cited by 67
Vpr and Its Cellular Interaction Partners: R We There Yet?
Fábryová, H., & Strebel, K. (2019) · Cells · doi:10.3390/cells8111310 · Cited by 56
Sulforaphane Inhibits HIV Infection of Macrophages through Nrf2
Furuya, A. K. M., Sharifi, H. J., Jellinger, R. M., Cristofano, P., Shi, B., & de Noronha, C. M. C. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005581 · Cited by 44
Illuminating the Role of Vpr in HIV Infection of Myeloid Cells
Nodder, S. B., & Gummuluru, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01606 · Cited by 38
Vpr Enhances Tumor Necrosis Factor Production by HIV-1-Infected T Cells
Roesch, F., Richard, L., Rua, R., Porrot, F., Casartelli, N., & Schwartz, O. (2015) · Journal of Virology · doi:10.1128/jvi.02098-15 · Cited by 37
Virion-Associated Vpr Alleviates a Postintegration Block to HIV-1 Infection of Dendritic Cells
Miller, C. M., Akiyama, H., Agosto, L. M., Emery, A., Ettinger, C. R., Swanstrom, R. I., Henderson, A. J., & Gummuluru, S. (2017) · Journal of Virology · doi:10.1128/jvi.00051-17 · Cited by 38
Mannose receptor is an HIV restriction factor counteracted by Vpr in macrophages
Lubow, J., Virgilio, M. C., Merlino, M., Collins, D. R., Mashiba, M., Peterson, B. G., Lukic, Z., Painter, M. M., Gomez-Rivera, F., Terry, V., et al. (2020) · eLife · doi:10.7554/elife.51035 · Cited by 35
“This structure is present on all HIV Env proteins that require Vpr for stability in macrophages [89.6, NL4-3 and AD8 (Mashiba et al., 2014; Collins et al., 2015).”
BackgroundMethodResultSelf-citationWang, Q., & Su, L. (2019) · mBio · doi:10.1128/mbio.01344-19 · Cited by 34
Rao, S., & Kumar, S. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12938 · Cited by 31
Vpr Is a VIP: HIV Vpr and Infected Macrophages Promote Viral Pathogenesis
Lubow, J., & Collins, K. L. (2020) · Viruses · doi:10.3390/v12080809 · Cited by 30
Self-citationAre Evolution and the Intracellular Innate Immune System Key Determinants in HIV Transmission?
Sumner, R. P., Thorne, L., Fink, D., Khan, H., Milne, R. S. B., & Towers, G. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01246 · Cited by 28
Fackler, O. (2015) · Viruses · doi:10.3390/v7122970 · Cited by 25
The Impact of Cellular Proliferation on the HIV-1 Reservoir
Virgilio, M., & Collins, K. L. (2020) · Viruses · doi:10.3390/v12020127 · Cited by 24
Self-citationMacrophage targeted nanocarrier delivery systems in HIV therapeutics
Khan, T. A., Patkar, M. M., Momin, M. M., & Omri, A. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1762565 · Cited by 23
Inlora, J., Chukkapalli, V., Bedi, S., & Ono, A. (2016) · Journal of Virology · doi:10.1128/jvi.01004-16 · Cited by 21
Hofmann, S., Dehn, S., Businger, R., Bolduan, S., Schneider, M., Debyser, Z., Brack‐Werner, R., & Schindler, M. (2017) · Open Biology · doi:10.1098/rsob.170115 · Cited by 19
HIV-1 Vpr combats the PU.1-driven antiviral response in primary human macrophages
Virgilio, M. C., Ramnani, B., Chen, T., Disbennett, W. M., Lubow, J., Welch, J. D., & Collins, K. L. (2024) · Nature Communications · doi:10.1038/s41467-024-49635-w · Cited by 14
Self-citationCRL4-DCAF1 Ubiquitin Ligase Dependent Functions of HIV Viral Protein R and Viral Protein X
Dobransky, A., Root, M., Hafner, N., Marcum, M., & Sharifi, H. J. (2024) · Viruses · doi:10.3390/v16081313 · Cited by 13
Recurrent Severe Subclinical Mastitis and the Risk of HIV Transmission Through Breastfeeding
Rutagwera, D. G., Molès, J., Kankasa, C., Mwiya, M., Tuaillon, É., Peries, M., Nagot, N., de Perre, P. V., & Tylleskär, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.822076 · Cited by 13
Activation of NRF2 blocks HIV replication and apoptosis in macrophages
Han, D., Lu, X., Yin, W., Fu, H., Zhang, X., Cheng, L., Liu, F., Jin, C., Tian, X., Xie, Y., et al. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12575 · Cited by 12
Help or Hinder: Protein Host Factors That Impact HIV-1 Replication
Moezpoor, M. R., & Stevenson, M. (2024) · Viruses · doi:10.3390/v16081281 · Cited by 7
Yucha, R., Litchford, M. L., Fish, C. S., Yaffe, Z. A., Richardson, B. A., Maleche‐Obimbo, E., John-Stewart, G. C., Wamalwa, D. C., Overbaugh, J. M., & Lehman, D. A. (2023) · Viruses · doi:10.3390/v15102055 · Cited by 5
HIV-1 Vpr increases HCV replication through VprBP in cell culture
Yan, Y., Huang, F., Yuan, T., Sun, B., & Yang, R. (2016) · Virus Research · doi:10.1016/j.virusres.2016.07.007 · Cited by 5
Fofana, J., Zahara, S., Chan, T., Zang, H., Reinhard, B. M., & Gummuluru, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-29002-5 · Cited by 5
Toward the unveiling of HIV-1 dynamics: Involvement of monocytes/macrophages in HIV-1 infection
Sukegawa, S., & Takeuchi, H. (2022) · Frontiers in Virology · doi:10.3389/fviro.2022.934892 · Cited by 4
Sato, H., Murakami, T., Matsuura, R., Abe, M., Matsuoka, S., Yashiroda, Y., Yoshida, M., Akari, H., Nagasawa, Y., Takei, M., et al. (2022) · Viruses · doi:10.3390/v14061321 · Cited by 4
Targeting HIV myeloid and central nervous system reservoirs for HIV cure
Grasberger, P. E., & Clayton, K. (2025) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000971 · Cited by 3
Schiff, A. E. (2019) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 1
Moisan, A. (2019) · theses.fr (ABES) · doi:10.70675/def1de33z9ba5z4d17za088z840fca71fd8f · Cited by 1
The Role of the HIV-1 Accessory Proteins Nef and Vpu in Subverting Host Cellular Immunity
Pawlak, E. N. (2018) · Scholarship@Western (Western University)
Emery, A. (2017) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/wm01-n347
Contre-mesures virales anti-CTIP2 dans le cadre d'une infection productive par le ViH-1
Forouzanfar, F. (2016) · theses.fr (ABES) · doi:10.70675/ceb9ed65z4c9dz45ecz94f2z1ea64b1f5e10
Mabanglo, M. F., Srivastava, S., Matsui, Y., Li, Z., Noureldin, M., Pogmore, J. P., Hoffer, L., Taherian, F., Hajian, T., Tucker, S., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00126
Rutagwera, D. G., Molès, J.-P., Kankasa, C., Mwiya, M., Tuaillon, E., Peries, M., Nagot, N., de Perre, P. V., & Tylleskär, T. (2022) · doi:10.3389/fimmu.2022.822076.s001
Metadata
- Authors
- Collins, D. R., Lubow, J., Lukic, Z., Mashiba, M., & Collins, K. L.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Collins, Kathleen L.
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-07-17
- Volume
- 11
- Issue
- 7
- Pages
- e1005054
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC4506080
- OpenAlex
- W2155484127
- Cited by
- 34
- References
- 51
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2022: 4 · 2021: 2 · 2020: 4 · 2019: 5 · 2018: 2 · 2017: 4 · 2016: 6 · 2015: 2
- FWCI
- 2.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Burroughs Wellcome Fund
- University of Michigan
- National Institutes of Health (5t32ai007413-32, T32 AI00,7413)
- National Institute of General Medical Sciences (T32GM007863, T32GM008353, T32GM145304)
- National Institute of Allergy and Infectious Diseases (T32-AI-007413, R01AI046998, R56AI051192, T32AI007528, R01AI051192)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- HIV-1 Vpr, DCAF1, cell-to-cell viral spread, CD4+ T cells, virological synapse, HIV-1 envelope glycoprotein, LAMP1, lysosomal degradation, interferon-alpha, antiviral restriction
- MeSH terms
- Humans, Macrophages, Virion, CD4-Positive T-Lymphocytes, HIV-1, Interferon-alpha, vpr Gene Products, Human Immunodeficiency Virus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.